Effect of Zanthoxylum Nitidum Tincture for Paronychia Caused by Afatinib
- Conditions
- Paronychia
- Interventions
- Drug: zanthoxylum nitidum tincture
- Registration Number
- NCT03908892
- Brief Summary
This is a randomized control trial evaluating the efficacy of zanthoxylum nitidum tincture on preventing progression of paronychia caused by afatinib from grade 1 to grade 2/3. Enrolled participates will randomly receive original treatment or original treatment plus zanthoxylum nitidum tincture immersion of the sick nail(s).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 110
- Pathologically or cytologically confirmed non-small cell lung cancer;
- Undergoing treatment with afatinib;
- With grade 1 paronychia;
- Age between 18 to 80 years old;
- Estimated life expectancy of more than months;
- With the written informed consent.
- Paronychia before afatinib treatment;
- Grade 2 or severer paronychia;
- Stop using afatinib or with reduced dose of afatinib;
- Currently diagnosed with severe encephalopathy or psychiatric disorders affecting patients ability of self expression.
- Has other legal, medical or ethical reasons that patients are not appropriate for clinical study.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Combination group zanthoxylum nitidum tincture Local use of 1% tetracycline ointment for the sick nail(s), 3 times a day, plus local application with zanthoxylum nitidum tincture soaked blocks for the sick nail(s) for 30 minutes, twice a day, till paronychia relief or progression. Combination group tetracycline ointment Local use of 1% tetracycline ointment for the sick nail(s), 3 times a day, plus local application with zanthoxylum nitidum tincture soaked blocks for the sick nail(s) for 30 minutes, twice a day, till paronychia relief or progression. Control group tetracycline ointment Local use of 1% tetracycline ointment for the sick nail(s), 3 times a day, till paronychia relief or progression.
- Primary Outcome Measures
Name Time Method Paronychia progress rate Through study completion, an average of 10 days. Incidence of grade 2 or more paronychia during paronychia treatment period will be reported. This period will be from randomization till paronychia relief or progression. Frequency of evaluation for paronychia will be everyday.
- Secondary Outcome Measures
Name Time Method Time to paronychia progress Through study completion, an average of 10 days. The time elapsed from randomization to either the date of grade 2 or more paronychia occurrence, treatment completion, or last follow-up information. Frequency of evaluation for paronychia will be everyday.
Time to paronychia relief Through study completion, an average of 10 days. The time elapsed from randomization to either the date of paronychia relief, treatment completion, or last follow-up information. Paronychia relief is defined as that paronychia disappears. Frequency of evaluation for paronychia will be everyday.
Trial Locations
- Locations (1)
Guangdong Provincial Hospital of Chinese Medicine
🇨🇳Guangzhou, Guangdong, China